The Companion Diagnostics Deals and Alliances of 2014 report provides comprehensive understanding and unprecedented access to the partnering deals and agreements entered into by the worlds leading healthcare companies during 2014.
Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2014’s dealmaking and business activities.
Chapter 1 provides an overview of the trends in dealmaking during 2014 covering trends by deal type, technology type and therapeutic indication.
Chapter 2 provides a comprehensive listing of leading deals by deal values, most active dealmakers, big pharma and big biotech deal activity.
Chapter 3 provides a comprehensive listing of leading deals of 2014 listed by big pharma company profiles, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Chapter 4 provides a comprehensive listing of leading deals of 2014 listed by big biotech company profiles, as well as contract documents available in the public domain. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
Chapter 5 provides a comprehensive directory of all partnering deals announced during 2014. The chapter is organized by company A-Z, deal type (collaborative R&D, co-promotion, licensing etc), therapy area and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
The report also includes numerous tables and figures that illustrate the trends and activities in partnering and dealmaking during 2014.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of technologies and products during 2014.
Table Of Contents
Companion Diagnostics Deals and Alliances of 2014 Executive Summary
Chapter 1 - Trends in dealmaking during 2014
1.1 Introduction 1.2. Partnering by deal type 1.3. Partnering by industry sector 1.4. Partnering by stage of development 1.5. Partnering by technology type 1.6. Partnering by therapy area
Chapter 2 - Leading deals during 2014
2.1. Introduction 2.2 Most active partnering in 2014 2.3. Top deals by value during 2014 2.4. Big pharma dealmaking activity 2.5. Big biotech dealmaking activity
Chapter 3 - Big pharma deals during 2014
3.1. Introduction 3.2. How to use big pharma partnering deals 3.3. Big pharmapartnering company profiles
Chapter 4 - Big biotech deals during 2014
4.1. Introduction 4.2. How to use big biotech partnering deals 4.3. Big biotech partnering company profiles
Chapter 5 - Partnering deals directory 2014
5.1. Introduction 5.2. Company A-Z 5.3. By deal type 5.4. By stage of development 5.5. By technology type 5.6. By therapy area
About Wildwood Ventures Current Partnering Current Agreements
Table of figures Figure 1: Partnering by deal type during 2014 Figure 2: Partnering by industry sector during 2014 Figure 3: Partnering by stage of development during 2014 Figure 4: Partnering by technology type during 2014 Figure 5: Partnering by therapy area during 2014 Figure 6: Active drug delivery dealmaking activity-2014 Figure 7: Top deals by value during 2014 Figure 8: Big pharma - top 50 - January to December 2014 Figure 9: Big pharma deal frequency - 2014 Figure 10: Big biotech - top 50 - January to December 2014 Figure 11: Big biotech deal frequency - 2014